Scarica l'app Stockscreener
227.07
0.89%
-2.05
Dopo l'orario di chiusura:
228.96
1.89
+0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$229.12
Aprire:
$226.28
Volume 24 ore:
1.48M
Relative Volume:
0.64
Capitalizzazione di mercato:
$53.18B
Reddito:
$250.74B
Utile/perdita netta:
$1.55B
Rapporto P/E:
34.72
EPS:
6.5398
Flusso di cassa netto:
$4.39B
1 W Prestazione:
+0.48%
1M Prestazione:
-3.87%
6M Prestazione:
+5.67%
1 anno Prestazione:
+43.81%
Intervallo 1D:
$224.11
$227.78
Intervallo di 1 settimana:
$224.11
$234.02
Portata 52W:
$137.75
$243.21
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
227.07 | 53.72B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
865.51 | 99.52B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
312.23 | 60.54B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
85.17 | 9.64B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.59 | 1.25B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals - Yahoo Finance
Cardinal Health Inc (CAH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardinal Health Inc (CAH) Institutional Confidence - TradingKey
4 Medical Stocks With the Right Setup for Q2 Earnings Beats - TradingView
The Buyback Machine Hiding Behind Cardinal Health’s Thin Margins - Trefis
Cardinal Health Inc (CAH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
How Cardinal Health Inc. (CAH) Affects Rotational Strategy Timing - Stock Traders Daily
Cardinal Health stock trades steady as investors weigh recent earnings and segment trends - Ad-hoc-news.de
CAH|Cardinal Health Inc|Price:228.030|Chg%:+2.010 - TradingKey
Ohio’s Cardinal Health company acquires two medical supply companies for $360 million - NBC4 WCMH-TV
Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH? - Yahoo Finance
Cardinal Health stock trades steadily as recent earnings and guidance frame investor expectations - AD HOC NEWS
Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $255.6, Implies 16% Upside - TradingView
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health (CAH) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Mizuho Securities Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $240 - Moomoo
Citigroup Adjusts Price Target on Cardinal Health to $265 From $245, Maintains Buy Rating - Moomoo
Here's What to Expect From Cardinal Health's Next Earnings Report - Barchart.com
Cardinal Health stock trades steady as investors weigh recent earnings and healthcare distribution m - AD HOC NEWS
Cardinal Health (CAH) Is Buying Strive Medical And AdaptHealth Diabetes Business - Sahm
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Deals tracker: Cross Country Healthcare acquired by Knox Lane - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Neogen (NEOG) and Cardinal Health (CAH) - The Globe and Mail
Cardinal Health Expands Home Care Business With Two Acquisitions - Zacks Investment Research
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Neogen (NEOG) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH) and Neogen (NEOG) - The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardinal Health (CAH) and Neogen (NEOG) - The Globe and Mail
Baird Adjusts Price Target on Cardinal Health to $251 From $248, Maintains Outperform Rating - Moomoo
Cardinal Health puts $360 million toward two acquisitions that expand home care business - DOTmed
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health stock trades steadily as investors weigh recent earnings and dividend support - AD HOC NEWS
Cardinal Health Expands Home Care Business With Two Strategic Acquisitions - HLTH
Cardinal Health acquires two home-care businesses for $360M - The Business Journals
Cardinal Health stock trades steady as recent earnings highlight margin focus - AD HOC NEWS
Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions - Yahoo Finance UK
Cardinal Health Expands Home Care Business with $360M Acquisition Pair - Modern Distribution Management
Cardinal Health stock trades steady as recent quarterly earnings highlight margin pressures and dive - AD HOC NEWS
AdaptHealth to sell business unit to Cardinal Health for $235M - The Business Journals
Cardinal Health makes acquisition duo worth $360m for home care business advance - Yahoo Finance
Cardinal inks 2 acquisitions in bid to expand at-home services - Healthcare Dive
CARDINAL HEALTH, INC : UBS RAISES TARGET PRICE TO $274 FROM $260 - webull.com
Cardinal Health to Acquire 2 Firms to Boost at-Home Solutions - Medical Product Outsourcing
Cardinal Health expands home care business with two tuck-in acquisitions - Morningstar
Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million - 101 WIXX
AdaptHealth sells diabetes unit to Cardinal Health for $235M By Investing.com - Investing.com Nigeria
Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Cardinal Health (CAH) Expands Portfolio with Strategic Acquisiti - GuruFocus
Cardinal Health to Buy AdaptHealth Diabetes Business, Strive Medical for $360 Million - Moomoo
Cardinal Health Acquires Two Medical Companies to Boost Home Solutions - Intellectia AI
Cardinal Health Agrees to Buy Strive Medical, AdaptHealth's Mail-Order Diabetes Business For $360M - Moomoo
AdaptHealth sells diabetes unit to Cardinal Health for $235M - Investing.com
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cardinal Health Inc Azioni (CAH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Greene Michelle D. | Chief Information Officer |
Feb 27 '26 |
Sale |
228.47 |
2,746 |
627,387 |
12,230 |
2.00%
8.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):